Source: SEBI
What would have to hold for each case — not a price target or a projected figure. CapitSignal does not forecast where this stock trades.
The Indian specialty chemical market continues to grow at projected rates.
The market is projected to grow from USD 64 billion in FY 2025 to USD 91 billion by FY 2030, reflecting a CAGR of 7.2%.
Successful investments in Altra Agro-Chem and Altra Pharma-Chem lead to increased production capacity.
The net proceeds from the fresh issue are proposed to be utilized for investments in these companies.
Revenue growth follows the historical trend as outlined in the filing.
Revenue from Sale of Products increased from ₹14,257.61 million in Fiscal 2023 to ₹16,248.92 million in Fiscal 2025.
The company maintains its current customer base and distribution relationships.
The company derives a substantial portion of its revenue from its distribution business, which accounted for 95.65% to 100.00% of product sales.
A significant customer or supplier relationship is lost.
Top 10 customers contributed 27.04% to 32.64% of revenue, indicating high customer concentration risk.
Disruptions in international supply chains affect product availability.
The company imports significant chemical products, with international purchases representing 26.56% to 33.61% of total purchases.